Amgen News
Most Popular Amgen Story
Report: Amgen's Sharer sounds out Actelion chief on buyout offer
For weeks now Amgen ($AMGN) has repeatedly been named as one of the most motivated suitors considering a takeover of Actelion. Interested in the blockbuster sales potential of Tracleer, a drug used... Read more...
Latest Headlines
- December 13, 2010
- November 23, 2010
- November 22, 2010
- November 19, 2010
- November 18, 2010
- November 17, 2010
- November 2, 2010
- November 2, 2010
- June 10, 2010
- June 2, 2010
- June 1, 2010
- May 17, 2010
- February 9, 2010
- February 2, 2010
- January 14, 2010
Paid Research Reports
- Russia Pharmaceutical Market Overview - Pharma companies target Russia despite the challenges it presents
- Stakeholder Insight: Breast Cancer (Hormone Receptor-Negative) - Triple-negative breast cancer offers a significant opportunity
- Infectious Diseases Vaccine Market Overview
- Commercial Insight: Top 20 Cancer Therapy Brands
- Strategies for Managing Pharmaceutical Workforce and Site Reductions: Analysis of legal, productivity, and quality control issue
- The Top 10 Biotechnology Companies: Positioning, performance and SWOT analyses
